Ignite Creation Date:
2025-12-25 @ 3:08 AM
Ignite Modification Date:
2025-12-31 @ 10:58 AM
Study NCT ID:
NCT05056233
Status:
COMPLETED
Last Update Posted:
2023-02-22
First Post:
2021-09-15
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Systane Hydration in Subjects Undergoing Cataract Surgery
Sponsor:
Organization:
Raw JSON
{'hasResults': False, 'derivedSection': {'miscInfoModule': {'versionHolder': '2025-12-24'}, 'conditionBrowseModule': {'meshes': [{'id': 'D015352', 'term': 'Dry Eye Syndromes'}, {'id': 'D002386', 'term': 'Cataract'}], 'ancestors': [{'id': 'D007766', 'term': 'Lacrimal Apparatus Diseases'}, {'id': 'D005128', 'term': 'Eye Diseases'}, {'id': 'D007905', 'term': 'Lens Diseases'}]}}, 'protocolSection': {'designModule': {'phases': ['NA'], 'studyType': 'INTERVENTIONAL', 'designInfo': {'allocation': 'RANDOMIZED', 'maskingInfo': {'masking': 'DOUBLE', 'whoMasked': ['INVESTIGATOR', 'OUTCOMES_ASSESSOR']}, 'primaryPurpose': 'TREATMENT', 'interventionModel': 'PARALLEL'}, 'enrollmentInfo': {'type': 'ACTUAL', 'count': 35}}, 'statusModule': {'overallStatus': 'COMPLETED', 'startDateStruct': {'date': '2022-01-18', 'type': 'ACTUAL'}, 'expandedAccessInfo': {'hasExpandedAccess': False}, 'statusVerifiedDate': '2023-02', 'completionDateStruct': {'date': '2023-01-12', 'type': 'ACTUAL'}, 'lastUpdateSubmitDate': '2023-02-21', 'studyFirstSubmitDate': '2021-09-15', 'studyFirstSubmitQcDate': '2021-09-15', 'lastUpdatePostDateStruct': {'date': '2023-02-22', 'type': 'ACTUAL'}, 'studyFirstPostDateStruct': {'date': '2021-09-24', 'type': 'ACTUAL'}, 'primaryCompletionDateStruct': {'date': '2023-01-12', 'type': 'ACTUAL'}}, 'outcomesModule': {'primaryOutcomes': [{'measure': 'Corneal staining', 'timeFrame': 'Up to Day 30 post-operative', 'description': 'The National Eye Institute (NEI) grading scale will be used to evaluate the five corneal regions: Superior, inferior, central, temporal and nasal. Each region will be graded on a 0-3 scale, where 0 = normal (no staining), 1 = mild/superficial stippling micropunctate staining, 2 = moderate/macropunctate staining with some coalescent areas, and 3 = severe/numerous coalescent macropunctate areas and/or patches. The regions will be summed for a resultant overall score of 0 to 15.'}], 'secondaryOutcomes': [{'measure': 'DEQ-5 Score', 'timeFrame': 'Up to Day 30 post-operative', 'description': 'The Dry Eye Questionnaire-5 (DEQ-5) is a patient-reported outcome measures questionnaire designed to assess symptoms of dry eye disease. Subjects will respond to 5 questions using a 0-4 Likert-type scale, for a resultant overall score of 0 (best) to 20 (worst).'}, {'measure': 'Ocular Comfort Questionnaire Score: My eyes are comfortable', 'timeFrame': 'Up to Day 30 post-operative', 'description': 'Subjects will provide a comfort score (strongly disagree, disagree, neither agree nor disagree, agree, strongly agree) to the following question: "My eyes are comfortable."'}, {'measure': 'Ocular Comfort Questionnaire Score: At the end of the day, my eyes feel comfortable', 'timeFrame': 'Up to Day 30 post-operative', 'description': 'Subjects will provide a comfort score (strongly disagree, disagree, neither agree nor disagree, agree, strongly agree) to the following question: "At the end of the day, my eyes feel comfortable."'}, {'measure': 'Ocular Comfort Questionnaire Score: My eyes are comfortable all day long', 'timeFrame': 'Up to Day 30 post-operative', 'description': 'Subjects will provide a comfort score (strongly disagree, disagree, neither agree nor disagree, agree, strongly agree) to the following question: "My eyes are comfortable all day long."'}]}, 'oversightModule': {'oversightHasDmc': False, 'isFdaRegulatedDrug': False, 'isFdaRegulatedDevice': False}, 'conditionsModule': {'conditions': ['Dry Eye Disease', 'Cataract']}, 'descriptionModule': {'briefSummary': 'The primary objective of this study is to demonstrate reduced corneal staining with use of Systane Hydration among subjects with dry eye disease (DED) undergoing routine cataract removal and monofocal intraocular lens (IOL) implantation.', 'detailedDescription': 'Subjects will attend 6 scheduled study visits for an individual duration of participation of 6 weeks. One eye (study eye) will be followed.'}, 'eligibilityModule': {'sex': 'ALL', 'stdAges': ['ADULT', 'OLDER_ADULT'], 'minimumAge': '18 Years', 'healthyVolunteers': False, 'eligibilityCriteria': 'Key Inclusion Criteria:\n\n* Seeking routine (age-related) cataract extraction with monofocal intraocular lens implantation;\n* Able to provide informed consent;\n* Willing and able to attend all study visits and comply with treatment;\n* Have dry eyes per dry eye questionnaire.\n* Other protocol-defined inclusion criteria may apply.\n\nKey Exclusion Criteria:\n\n* Subjects who use of ocular drugs, other than the test article (for treatment group only) and other standard of care postoperative medications, during the study;\n* History of intraocular or corneal surgery in the study eye;\n* Use of artificial tears, steroids, or other medications as specified in the protocol;\n* Clinically significant corneal scarring;\n* Corneal degeneration, retinal degeneration or other ocular pathology as specified in the protocol.\n* Other protocol-specified exclusion criteria may apply.'}, 'identificationModule': {'nctId': 'NCT05056233', 'briefTitle': 'Systane Hydration in Subjects Undergoing Cataract Surgery', 'organization': {'class': 'INDUSTRY', 'fullName': 'Alcon Research'}, 'officialTitle': 'Systane Hydration in Subjects Undergoing Cataract Surgery', 'orgStudyIdInfo': {'id': 'DER646-P001'}}, 'armsInterventionsModule': {'armGroups': [{'type': 'EXPERIMENTAL', 'label': 'Systane Hydration', 'description': 'Systane Hydration lubricant eye drops dosed 4 times a day for 6 weeks (2 weeks prior to surgery and 4 weeks post surgery), with investigator defined post-operative standard of care', 'interventionNames': ['Other: Systane Hydration lubricant eye drops']}, {'type': 'NO_INTERVENTION', 'label': 'No Treatment', 'description': 'Investigator defined post-operative standard of care'}], 'interventions': [{'name': 'Systane Hydration lubricant eye drops', 'type': 'OTHER', 'otherNames': ['Systane Hydration® Ophthalmic Solution'], 'description': 'Sterile solution indicated for the temporary relief of burning and irritation due to dryness of the eye', 'armGroupLabels': ['Systane Hydration']}]}, 'contactsLocationsModule': {'locations': [{'zip': '47012', 'city': 'Valladolid', 'country': 'Spain', 'facility': 'Principal Investigator', 'geoPoint': {'lat': 41.65541, 'lon': -4.72353}}], 'overallOfficials': [{'name': 'Sr. Clinical Trial Lead, CDMA Surgical', 'role': 'STUDY_DIRECTOR', 'affiliation': 'Alcon Research, LLC'}]}, 'ipdSharingStatementModule': {'ipdSharing': 'NO'}, 'sponsorCollaboratorsModule': {'leadSponsor': {'name': 'Alcon Research', 'class': 'INDUSTRY'}, 'responsibleParty': {'type': 'SPONSOR'}}}}